Screening compound: InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3

Screening compound: InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3
Screening compound: InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F828-0903

Molecular Formula

C22H22ClN3O2S (C22 H22 ClN3 O2 S)

Compound Name

1-{[1-(4-chlorophenyl)-3,5-dimethyl-1H-pyrazol-4-yl]sulfonyl}-4-phenyl-1,2,3,6-tetrahydropyridine

IUPAC name

1-{[1-(4-chlorophenyl)-35-dimethyl-1H-pyrazol-4-yl]sulfonyl}-4-phenyl-1236-tetrahydropyridine

SMILES

Cc(n(-c(cc1)ccc1Cl)nc1C)c1S(N(CC1)CC=C1c1ccccc1)(=O)=O

InChI

InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3

InChI Key

KATHXMODUOSUJB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27196306

InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3?
Check Price and Availability of InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C22H22ClN3O2S/c1-16-22(17(2)26(24-16)21-10-8-20(23)9-11-21)29(27,28)25-14-12-19(13-15-25)18-6-4-3-5-7-18/h3-12H,13-15H2,1-2H3 available by request